Your browser doesn't support javascript.
loading
Real-world effectiveness of ixazomib combined with lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: the REMIX study.
Macro, M; Hulin, C; Vincent, L; Charvet-Rumpler, A; Benboubker, L; Calmettes, C; Stoppa, A-M; Laribi, K; Clement-Filliatre, L; Zerazhi, H; Honeyman, F; Richez, V; Maloisel, F; Karlin, L; Barrak, J; Chouaid, C; Leleu, X.
Afiliação
  • Macro M; IHBN - CHU de Caen, Caen, France. macro-m@chu-caen.fr.
  • Hulin C; CHU Bordeaux - Hôpital Haut Leveque, Pessac, France.
  • Vincent L; CHU de Montpellier - Hôpital Saint-Eloi, Montpellier, France.
  • Charvet-Rumpler A; CHU de Besançon - Hôpital Jean Minjoz, Besançon, France.
  • Benboubker L; CHRU de Tours - Hôpital Bretonneau, Tours, France.
  • Calmettes C; CH de Périgueux, Périgueux, France.
  • Stoppa AM; Institut Paoli Calmettes, Marseille, France.
  • Laribi K; CH Le Mans, Le mans, France.
  • Clement-Filliatre L; Clinique Louis Pasteur, Essey-lès-Nancy, France.
  • Zerazhi H; CH d'Avignon, Avignon, France.
  • Honeyman F; CHU de Saint-Etienne, Saint-Etienne, France.
  • Richez V; CHU de Nice - Hôpital de l'archet, Nice, France.
  • Maloisel F; Clinique Sainte-Anne, Strasbourg, France.
  • Karlin L; Hospices Civils de Lyon, Pierre Bénite, France.
  • Barrak J; Takeda France, Paris, France.
  • Chouaid C; CHI de Créteil, Créteil, France.
  • Leleu X; CHU de Poitiers, Poitiers, France.
Ann Hematol ; 102(8): 2137-2151, 2023 Aug.
Article em En | MEDLINE | ID: mdl-37301786
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Aged / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Aged / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article